Related Experiment Videos
Emergency department management of pediatric migraine
1Department of Pediatrics, Winnipeg Children's Hospital, Manitoba, Canada.
Insights
Pediatric migraine treatment requires individualized approaches due to its complex causes. Initial therapies include common pain relievers, with advanced options like triptans considered for persistent cases.
Area of Science:
- Pediatric Emergency Medicine
- Neurology
- Pharmacology
Background:
- Migraine is a frequent and complex condition presenting in pediatric emergency departments.
- The multifactorial pathophysiology of pediatric migraine suggests a need for diverse treatment strategies.
Purpose of the Study:
- To review current and emerging treatment options for pediatric migraine.
- To emphasize individualized treatment plans based on patient response and migraine complexity.
Main Methods:
- Literature review of existing studies on pediatric migraine treatments.
- Discussion of therapeutic agents targeting different pathophysiological pathways (dopaminergic, serotonergic, inflammatory).
Main Results:
- Simple analgesics (acetaminophen, aspirin, NSAIDs) are recommended as first-line treatments.
- Dihydroergotamine and dopamine antagonists are suitable for more specific therapies.
- Triptans and dexamethasone may be considered for adolescents and prolonged headaches, respectively.
- Monotherapy is often insufficient, highlighting the potential of combination therapies.
Conclusions:
- Individualized treatment is crucial for pediatric migraine management.
- Combination therapy targeting multiple etiological pathways may improve treatment efficacy.
- Further research into combination therapies for pediatric migraine is warranted.
Abstract:
Migraine is a common pediatric emergency department problem. Since its pathophysiology is unclear and possibly multifactorial, a single treatment strategy is unlikely to be successful for all patients. A specific treatment that has been successful for a particular patient should be strongly considered. Otherwise, it is best to start with simple therapies such as acetaminophen, aspirin, or an NSAID if not already tried at home. For patients requiring more specific therapy, reasonable choices would be dihydroergotamine or a dopamine antagonist such as prochlorperazine. There are several newer agents studied in adults with examples being sumatriptan and naratriptan. These probably have a role in the adolescent and should be considered in the younger age group when other therapies have failed. When the headache has been prolonged, dexamethasone may be useful in decreasing inflammation and relieving pain. As illustrated in many of the above studies, monotherapy is often inadequate in achieving complete relief of headache pain in all patients. Most of the drugs discussed here address only one of the three etiologies thought to be involved in migraine pathogenesis, namely; the dopaminergic system. the serotonin system or inflammation. Presumably, therapy directed toward more than one of these etiologies at the same time may be more effective (11).